Head-to-head comparison of <sup>18</sup>F-FAPI and <sup>18</sup>F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma.

Authors:
Zhang J; Jiang S; Li M; Xue H; Zhong X and 11 more

Journal:
Cancer Imaging

Publication Year: 2023

DOI:
10.1186/s40644-023-00626-y

PMCID:
PMC10614420

PMID:
37899452

Journal Information

Full Title: Cancer Imaging

Abbreviation: Cancer Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Affiliated Cancer Hospital & Institute of Guangzhou Medical University. Consent for publicationNot applicable. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

Evidence found in paper:

"Funding This work was supported by National Natural Science Foundation of China (Grant No.82101994) and Affiliated Cancer Hospital & Institute of Guangzhou Medical University Clinical Research 5555 Program [No. IIT-2022–015(HYX)]."

Evidence found in paper:

"Trial registration Clinical Trials, NCT05485792. Registered 1 August 2022, Retrospectively registered."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025